EQTEC PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.25 GBX | 0.00% |
|
-20.63% | -58.33% |
| May. 08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
| May. 08 | EQTEC plc Announces Drawdown on Syndicated Facility and Other Funding Updates | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5.358 | 199.1 | 121.3 | 26.23 | 2.639 | 2.639 | - |
| Enterprise Value (EV) 1 | 5.358 | 193.9 | 115.1 | 30.7 | 4.639 | 5.529 | 5.959 |
| P/E ratio | -1.36 x | - | -14.4 x | -3.05 x | -0.21 x | -0.93 x | 3.23 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.18 x | 89.1 x | 13.2 x | 3.29 x | 1.23 x | 0.5 x | 0.16 x |
| EV / Revenue | 3.18 x | 86.8 x | 12.6 x | 3.85 x | 2.16 x | 1.04 x | 0.36 x |
| EV / EBITDA | - | -42.6 x | -31.9 x | -6.75 x | -0.89 x | -1.1 x | 1.76 x |
| EV / FCF | - | - | -7,010,094 x | -2,091,414 x | - | - | - |
| FCF Yield | - | - | -0% | -0% | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,394 | 68,687 | 84,278 | 85,990 | 181,486 | 181,486 | - |
| Reference price 2 | 0.1360 | 2.898 | 1.440 | 0.3050 | 0.0145 | 0.0145 | 0.0145 |
| Announcement Date | 6/15/20 | 4/19/21 | 4/25/22 | 5/5/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.686 | 2.235 | 9.172 | 7.97 | 2.144 | 5.326 | 16.63 |
| EBITDA 1 | - | -4.549 | -3.607 | -4.551 | -5.213 | -5.028 | 3.384 |
| EBIT 1 | - | -4.633 | -3.836 | -4.914 | -4.581 | -4.217 | -2.2 |
| Operating Margin | - | -207.3% | -41.82% | -61.66% | -213.72% | -79.17% | -13.23% |
| Earnings before Tax (EBT) 1 | - | - | -4.7 | -10.46 | -7.09 | -4.582 | -2.61 |
| Net income 1 | - | - | -4.7 | -10.53 | -7.11 | -4.602 | -1.6 |
| Net margin | - | - | -51.25% | -132.06% | -331.7% | -86.41% | -9.62% |
| EPS 2 | -0.1000 | - | -0.1000 | -0.1000 | -0.0678 | -0.0157 | 0.004500 |
| Free Cash Flow | - | - | -16.42 | -14.68 | - | - | - |
| FCF margin | - | - | -179.07% | -184.2% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 6/15/20 | 4/19/21 | 4/25/22 | 5/5/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|
| Net sales 1 | - | 4.989 | - | 2.1 |
| EBITDA | - | - | - | - |
| EBIT 1 | - | -2.942 | - | -1.8 |
| Operating Margin | - | -58.97% | - | -85.71% |
| Earnings before Tax (EBT) 1 | - | -8.184 | - | -1.7 |
| Net income 1 | -2.28 | -8.245 | -2.425 | -1.7 |
| Net margin | - | -165.26% | - | -80.95% |
| EPS | -0.0300 | - | -0.0200 | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 9/30/22 | 5/5/23 | 9/28/23 | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 4.48 | 2 | 2.89 | 3.32 |
| Net Cash position 1 | - | 5.18 | 6.19 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.9839 x | -0.3837 x | -0.5748 x | 0.9811 x |
| Free Cash Flow | - | - | -16.4 | -14.7 | - | - | - |
| ROE (net income / shareholders' equity) | - | -25.4% | -12.8% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | - | - | - | -0.1200 | -0 | -0.0300 | -0 |
| Capex 1 | - | - | 1 | 0.08 | 0.01 | 0.11 | 0.01 |
| Capex / Sales | - | - | 10.9% | 0.99% | 0.47% | 1.97% | 0.06% |
| Announcement Date | 6/15/20 | 4/19/21 | 4/25/22 | 5/5/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0145
EUR
Average target price
0.704
EUR
Spread / Average Target
+4,742.09%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -57.00% | 2.85M | |
| +17.24% | 20.85B | |
| +104.42% | 20.42B | |
| -25.17% | 6.39B | |
| -15.15% | 3.18B | |
| -20.72% | 2.47B | |
| -24.88% | 1.92B | |
| -21.04% | 1.21B | |
| -0.54% | 1.02B | |
| -9.49% | 947M |
- Stock Market
- Equities
- REAC Stock
- Financials EQTEC plc
